Allscripts Acquires Oasis Medical Solutions

AllscriptsAllscripts (NASDAQ: MDRX) announced the acquisition of privately-held Oasis Medical Solutions Limited, a London-based Patient Administration System (PAS) and health informatics solution provider. The OasisTM PAS system, developed over 18 years in partnership with numerous NHS trusts, provides flexible, efficient and scalable administrative workflow across all venues of care. By combining the Oasis PAS technology with the Allscripts Sunrise clinical platform, Allscripts will offer a highly competitive, single-source offering for an innovative and advanced electronic patient record solution throughout the United Kingdom.

The Oasis PAS is used extensively across the NHS in more than a dozen NHS trusts and hospitals. Clients include East Sussex Healthcare, Royal Surrey County Hospital Trust, Medway NHS Foundation Trust and Worcestershire Acute Hospitals NHS Trust, among others. Oasis hospital clients average over 500 beds per facility, and the company has distinguished itself for its exclusive focus on PAS solutions for the NHS trusts that are innovative, effective, affordable and flexible.

Allscripts has a proven track record of success for clinical solutions, specifically the Allscripts Sunrise clinical electronic health record for inpatient and outpatient care management. Today, Sunrise is live at Liverpool Heart and Chest Hospital NHS Foundation Trust as well as at Salford Royal NHS Foundation Trust. In addition, Allscripts recently announced the opening of its European headquarters in Manchester, UK, committing additional resources to this important healthcare market.

By combining a leading PAS offering with its advanced clinical solution, Allscripts will provide the UK NHS trusts with the clear long-term advantages of integrated workflow between PAS and clinical solutions and the benefit of one business partner that provides a single-source electronic patient record to improve the efficiency and quality of healthcare delivery.

"The United Kingdom is an important growth market for Allscripts core clinical and PAS solutions," said Richard Berner, President, Allscripts International. "A strong clinical offering combined with a highly regarded PAS provides a complete and proven solution to meet the critical long-term needs of the NHS Trusts. By acquiring Oasis, we believe we have optimised our position in the market and expect to drive significant value from this combination for our clients."

Terms of the acquisition were not disclosed.

About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of HealthTM. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...